Author: Daniel Wilson

(Bloomberg) — The tariff throwdown between Donald Trump and Justin Trudeau has slowed Canadian corporate bond sales to a trickle over the past week as investors demand a higher premium to hold loonie debt. Most Read from Bloomberg The US president’s looming 25% tariff on Canadian goods — which briefly took effect last week before being paused until April — threatens to send the Canadian economy spiraling into a recession, spurring job losses and price spikes that fuel inflation. Canada’s vulnerability in the trade war has bubbled up in a credit market that has historically been largely indifferent to macro…

Read More

(Bloomberg) — The US administration of Donald Trump is giving Chevron Corp. one month to stop producing oil in Venezuela, delivering a heavy blow to President Nicolas Maduro’s autocratic regime. Most Read from Bloomberg The US Treasury set an April 3 deadline for the oil major to wrap up operations in the country, much less than the normal six-month wind-down period. The narrow time frame is an unexpected hit to Maduro, significantly ratcheting up pressure on him to quickly make a deal over democratic reforms and accepting more migrants from the US. “Closing down Chevron’s operations in a month is…

Read More

OAKLAND, Calif. (AP) — A federal judge has denied Elon Musk’s request for a court order blocking OpenAI from converting itself to a for-profit company but said she could expedite a trial to consider Musk’s claims against the ChatGPT maker and its CEO. U.S. District Judge Yvonne Gonzalez Rogers ruled late Tuesday that “Musk has not demonstrated likelihood of success on the merits” in his request for a preliminary injunction. She offered to hold a trial in her California courtroom as soon as this fall, “given the public interest at stake and potential for harm if a conversion contrary to…

Read More

Veeva Systems (NYSE:VEEV) Beats Q4 Sales Targets, Stock Soars Healthcare software provider Veeva Systems (NASDAQ:VEEV) reported Q4 CY2024 results exceeding the market’s revenue expectations , with sales up 14.3% year on year to $720.9 million. The company expects next quarter’s revenue to be around $727.5 million, close to analysts’ estimates. Its non-GAAP profit of $1.74 per share was 10.1% above analysts’ consensus estimates. Is now the time to buy Veeva Systems? Find out in our full research report. Revenue: $720.9 million vs analyst estimates of $699.1 million (14.3% year-on-year growth, 3.1% beat) Adjusted EPS: $1.74 vs analyst estimates of $1.58…

Read More

European defense stocks surged on Monday after leaders met with Zelenskyy in London. Ukraine’s president left Washington on Friday without a minerals deal after clashing with Trump. Rheinmetall, BAE Systems, and Leonardo rose sharply amid expectations of higher defense spending. European defense stocks surged again on Monday as the UK, France, and Ukraine agreed to work on a peace deal following Volodymyr Zelenskyy’s clash with President Donald Trump. European leaders met with the Ukraine president in London on Sunday. Expectations of rising demand for weapons and other military equipment are behind the stock surges on European markets. UK Prime Minister…

Read More

Sleep Number (NASDAQ:SNBR) Misses Q4 Revenue Estimates, Stock Drops Bedding manufacturer and retailer Sleep Number (NASDAQ:SNBR) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 12.3% year on year to $376.8 million. Its GAAP loss of $0.21 per share was 10.6% above analysts’ consensus estimates. Is now the time to buy Sleep Number? Find out in our full research report. Revenue: $376.8 million vs analyst estimates of $389.7 million (12.3% year-on-year decline, 3.3% miss) EPS (GAAP): -$0.21 vs analyst estimates of -$0.24 (10.6% beat) Adjusted EBITDA: $26.21 million vs analyst estimates of $28.9 million (7% margin, 9.3% miss)…

Read More

(Bloomberg) — Hon Hai Precision Industry Co. posted a 25% rise in revenue during the first two months of 2025, quickening from last year in a reflection of expanding demand for AI computing. Most Read from Bloomberg The main supplier of Nvidia Corp. AI servers and Apple Inc. iPhones, also known as Foxconn, reported sales of NT$1.1 trillion ($33.5 billion) for January and February. That’s an acceleration from the 11% growth pace it clocked in 2024. Analysts on average project a revenue increase of 22% to NT$1.6 trillion for the first quarter. The quickening follows Nvidia’s disclosure last week of…

Read More

(Bloomberg) — After a lifetime of dealmaking, 96-year-old Hong Kong billionaire Li Ka-shing may have just pulled off one of his boldest transactions yet. Most Read from Bloomberg Under pressure from the Trump administration over two ports at the Panama canal controlled by CK Hutchison Holdings Ltd., Li’s company announced a plan to sell off the bulk of its global ports business to a consortium led by BlackRock Inc. In return, the Hong Kong firm will receive cash proceeds of more than $19 billion. Investors, and even some of CK Hutchison’s closest advisers, were surprised that what began with two…

Read More

Yext (NYSE:YEXT) Posts Q4 Sales In Line With Estimates But Stock Drops Online reputation and search platform Yext (NYSE:YEXT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 11.9% year on year to $113.1 million. Its non-GAAP profit of $0.12 per share was 9.4% below analysts’ consensus estimates. Is now the time to buy Yext? Find out in our full research report. Revenue: $113.1 million vs analyst estimates of $112.8 million (11.9% year-on-year growth, in line) Adjusted EPS: $0.12 vs analyst expectations of $0.13 (9.4% miss) Adjusted EBITDA: $24.56 million vs analyst estimates of $24.84 million (21.7% margin,…

Read More

Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue Diagnostics company Guardant Health (NASDAQ:GH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 30.2% year on year to $201.8 million. Its GAAP loss of $0.90 per share was 12.4% below analysts’ consensus estimates. Is now the time to buy Guardant Health? Find out in our full research report. Revenue: $201.8 million vs analyst estimates of $192.6 million (30.2% year-on-year growth, 4.8% beat) EPS (GAAP): -$0.90 vs analyst expectations of -$0.80 (12.4% miss) Management’s revenue guidance for the upcoming financial year 2025 is $855 million at the midpoint Operating Margin: -62.4%,…

Read More